Welcome : Guest

Torii Pharmaceutical Co., Ltd. (Japan) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Torii Pharmaceutical Co., Ltd., which is principally involved in providing Pharmaceutical Products. Illustrated with 47 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-07590
Price: $2350
Company Type: Public
Pages: 49
Date: January 2017
Market Data Tables: 47

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Torii Pharmaceutical Co., Ltd.'s (Operations) Sales by Product Segment (2015) in Percentage for Remitch, Truvada, Antebate, Futhan, Stribild, Kayexalate, Urinorm, Riona, Dovonex, Zefnart,and Locoid......3
Table 2: Torii Pharmaceutical Co., Ltd.’s (Sales of Products) Sales by Category (2014) in Percentage for Remitch, Truvada, Antebate, Futhan, Stribild, Kayexalate, Bio-Three, Urinorm, Riona, Dovonex, Zefnart, Locoid, Magsent and Others......4
New Pharmaceutical Licensed Drugs......5
Table 3: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......5
Kidney Disease Drugs......6
Table 4: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......6
Table 5: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......7
Table 6: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......8
Table 7: Hemodialysis Market by Drug in the US ((2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......9
Table 8: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......10
Table 9: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......11
Table 10: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......12
Protease Inhibitors......13
Table 11: Protease Inhibitors Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for APTIVUS, KALETRA, PREZISTA, and REYATAZ......13
Dermatological Drugs......14
Table 12: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......14
Table 13: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......15
Table 14: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......16
Table 15: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......17
Acne Drugs......18
Table 16: Acne Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Isotretinoin, Topicals (Retinoid/Antibiotics), Oral Antibiotics, and Others......18
Table 17: Anti-acne Topical Dermatology Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Acne, AK + Psoriasis + Dermatitis + Others, Anti-Fungal Combo, Anti-Infective, Coagulants, Corticosteroids Combo, and Corticosteroids Plain......19
Table 18: Acne Drugs Market by Segments in the US (2015) - Percentage Share Breakdown by Volume for Orals and Topicals......20
Allergy Drugs......21
Table 19: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others......21
Table 20: Allergy Care Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others......22
Table 21: US Market (Private Label and Others) by Product (2015) - Percentage Share Breakdown by Values Sales for Allergy Care, Baby Food, Bakery, Bleach, Dairy, Deodorants, Hair Care, Ice Cream, Laundry Care, Oral Care, OTC, Pet Food, Pet Products, Retail Tissue, Sauces/Dressing, Skin Care, Sun Care, Toilet Care and VDS......23
Allergic Rhinitis Disease......24
Table 22: Allergic Rhinitis Disease Market by Classification in the US (2015) - Percentage Share Breakdown by Value for Mild Intermittent, Mild Persistent, Moderate-severe Intermittent, and Moderate-severe Persistent......24
Table 23: Allergic Rhinitis Disease Market by Treatment in the US (2015) - Percentage Share Breakdown by Value for Immunotherapy, OTC Treatments only, and Other Prescription......25
Table 24: Allergic Rhinitis Disease Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for International, North America, Northern and Central Europe, and Southern Europe......26
HIV Drugs......27
Table 25: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others (Includes NNRTIs)......27
Table 26: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......28
Table 27: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......29
Table 28: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......30
Phosphate Binder Drugs......31
Table 29: Market Shares of Leading Phosphate Binder Drugs for Treatment of Hyperkalemia and Hyperphosphatemia Worldwide (2015) - Percentage Share Breakdown by Value for Calcium Acetate, Sevelamer and Others......31
Dermatological Products......32
Table 30: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......32
Table 31: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......33
Table 32: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......34
Table 33: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......35
Acne Drugs......36
Table 34: Market Shares of Leading Branded Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, Inc., Galderma, Valeant Pharmaceuticals International, Inc. and Others......36
Table 35: Market Shares of Leading Branded Anti-acne Treatement Providers Worldwide (2015) - Percentage Share Breakdown by Value for Allergan, plc, Bayer AG, Galderma S.A., GlaxoSmithKline Pharmaceuticals Ltd., Prasco Laboratories, Valeant Pharmaceuticals International, Inc., and Others......37
Table 36: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......38
Table 37: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label......39
Table 38: Topical Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Managed Medicaid Payment, Medicare Payment......40
Table 39: Market Shares of Leading Topical Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Acanya, Aczone, Differin, Epiduo, Finacea, and Others......41
Table 40: Oral Prescription Acne Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Cash Payment, Commercial, and Medicare Payment......42
Table 41: Market Shares of Leading Oral Acne Treatment Brands in the US (2015) - Percentage Market Share Breakdown by Volume for Doryx, Monodox, Oracea, Solodyn, and Others......43
Allergy Care Products......44
Table 42: Market Shares of Leading Allergy Immunotherapy Treatment Providers Worldwide (2015) - Percentage Breakdown by Value for ALK-Abelló, Greer Laboratories, Inc., and Others......44
Table 43: Market Shares of Leading Allergy Immunotherapy Treatment Providers in the UK (2015) - Percentage Breakdown by Value for ALK, Allergopharma, Allergy Therapeutics, HAL Allergy, Leti/Novartis, Stallergenes, and Others......45
Table 44: Market Shares of Leading Allergy Care Product Companies by Value Sales in the US (2014) - Percentage Breakdown for Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Prestige Brands Holdings Inc., Sanofi S A, Private Label and Others......46
Table 45: Allergy Drug Market in the UK (2015) - Percentage Share Breakdown by Value for Allegra, Allelock, Clarinex, Claritin, Zyrtec, and Others......47
Table 46: Torii Pharmaceutical Co., Ltd.’s Sales by Business Segment (2013-2014) in ¥ Millions for Sales of Products and Rent Income from Real Estate......48
Table 47: Torii Pharmaceutical Co., Ltd.’s (Sales of Products) Sales by Product Segment (2013-2014) in Percentage for Renal Disease and Haemodialysis, Skin Disease and Allergens, HIV and Others......49